DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sarrazin C, Dvory-Sobol H, Svarovskaia ES. et al.
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir.
Gastroenterology 2016;
151: 501-512 e501
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.